606 related articles for article (PubMed ID: 24814343)
1. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
[TBL] [Abstract][Full Text] [Related]
2. Driving glioblastoma growth by alternative polyadenylation.
Han T; Kim JK
Cell Res; 2014 Sep; 24(9):1023-4. PubMed ID: 24993033
[TBL] [Abstract][Full Text] [Related]
3. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
4. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
5. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
[TBL] [Abstract][Full Text] [Related]
6. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
[TBL] [Abstract][Full Text] [Related]
7. CFIm25 regulates human stem cell function independently of its role in mRNA alternative polyadenylation.
Ran Y; Huang S; Shi J; Feng Q; Deng Y; Xiang AP; Yao C
RNA Biol; 2022; 19(1):686-702. PubMed ID: 35491945
[TBL] [Abstract][Full Text] [Related]
8. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
[TBL] [Abstract][Full Text] [Related]
9. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
[TBL] [Abstract][Full Text] [Related]
10. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
Masamha CP
Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
[TBL] [Abstract][Full Text] [Related]
11. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alternative polyadenylation by the C2H2-zinc-finger protein Sp1.
Song J; Nabeel-Shah S; Pu S; Lee H; Braunschweig U; Ni Z; Ahmed N; Marcon E; Zhong G; Ray D; Ha KCH; Guo X; Zhang Z; Hughes TR; Blencowe BJ; Greenblatt JF
Mol Cell; 2022 Sep; 82(17):3135-3150.e9. PubMed ID: 35914531
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.
Ge Y; Huang J; Chen R; Fu Y; Ling T; Ou X; Rong X; Cheng Y; Lin Y; Zhou F; Lu C; Yuan S; Xu A
PLoS Pathog; 2024 Feb; 20(2):e1012061. PubMed ID: 38416782
[TBL] [Abstract][Full Text] [Related]
15. Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor "CFIm25".
Tamaddon M; Shokri G; Hosseini Rad SMA; Rad I; Emami Razavi À; Kouhkan F
Sci Rep; 2020 Jul; 10(1):11608. PubMed ID: 32665581
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-181a promotes proliferation and inhibits apoptosis by suppressing CFIm25 in osteosarcoma.
Zhu ZJ; Huang P; Chong YX; Kang LX; Huang X; Zhu ZX; Nie L
Mol Med Rep; 2016 Nov; 14(5):4271-4278. PubMed ID: 27633853
[TBL] [Abstract][Full Text] [Related]
17. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
[TBL] [Abstract][Full Text] [Related]
18. Poly(A)-ClickSeq: click-chemistry for next-generation 3΄-end sequencing without RNA enrichment or fragmentation.
Routh A; Ji P; Jaworski E; Xia Z; Li W; Wagner EJ
Nucleic Acids Res; 2017 Jul; 45(12):e112. PubMed ID: 28449108
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression.
Lianoglou S; Garg V; Yang JL; Leslie CS; Mayr C
Genes Dev; 2013 Nov; 27(21):2380-96. PubMed ID: 24145798
[TBL] [Abstract][Full Text] [Related]
20. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression.
Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X
J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
